Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | NAMPT | P43490 | 1/20 | 0.59 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL664024 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL13593340 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL6383063 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL2331916 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| Salcaprozic Acid SCHEMBL4586235 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL14088979 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL14088978 | 1.00 | NAAA (0.70) | NAAAALDH1A1HTTNPC1MAPT | |
| Salcaprozic Acid SCHEMBL845833 | 0.98 | NAAA (0.68) | NAAAALDH1A1HTTNPC1MAPT | |
| Salcaprozic Acid SCHEMBL2159928 | 0.98 | NAAA (0.68) | NAAAALDH1A1HTTNPC1MAPT | |
| SCHEMBL2331880 | 0.98 | NAAA (0.68) | NAAAALDH1A1HTTNPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069697-A1 | METHOD OF TREATING CANCER | INTENSITY THERAPEUTICS INC (US) | 2026-03-12 | — | — | US | claimed |
| CN-119950684-A | Pharmaceutical composition containing bioactive substances and preparation method and application thereof | 北京悦康科创医药科技股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| EP-4284774-B1 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | NOVO NORDISK AS (DK) | 2025-03-12 | — | — | EP | claimed |
| EP-4429704-A1 | IONIC LIQUID COMPOSITIONS | I2O Therapeutics, Inc. (US) | 2024-09-18 | — | — | EP | claimed |
| CN-118541170-A | Ionic liquid composition | I2O治疗公司 | 2024-08-23 | — | — | CN | claimed |
| EP-4392020-A1 | LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) | 2024-07-03 | — | — | EP | claimed |
| CN-118063339-A | Preparation method of sodium 8- (2-hydroxybenzoylamino) octoate | 安徽大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117835969-A | Lyotropic liquid crystal nanosystems with encapsulated bioactive macromolecules | 联康药业克雷恩特塞提斯制药实验室有限责任公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117731624-A | Solid pharmaceutical composition comprising GLP-1 receptor agonist and application | 杭州澳赛诺生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117402073-A | Preparation method of 8- (2-hydroxybenzoyl) caprylic acid | 扬州市普林斯医药科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-115651230-B | PVC (polyvinyl chloride) coated polyester yarn and preparation method thereof | 浙江恒百华化纤有限公司 | 2023-11-14 | — | — | CN | claimed |
| US-20230338251-A1 | METHOD OF TREATING CANCER | INTENSITY THERAPEUTICS, INC. | 2023-10-26 | — | — | US | claimed |
| CN-116745261-A | Novel method for synthesizing 8- [ (2-hydroxybenzoyl) amino) octanoic acid (salcap acid) by amide formation | 诺和诺德股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116444392-A | Polypeptide protein medicine oral absorption promoter and preparation method and application thereof | 中国药科大学 | 2023-07-18 | — | — | CN | claimed |
| WO-2023086499-A1 | IONIC LIQUID COMPOSITIONS | I2O THERAPEUTICS, INC. (US) | 2023-05-19 | — | — | WO | claimed |
| CN-112898220-B | Preparation method of N- (8- [ 2-hydroxybenzoyl ] -amino) sodium caprylate and intermediate thereof | 旺山旺水(连云港)制药有限公司 | 2023-04-07 | — | — | CN | claimed |
| WO-2023026067-A1 | LYOTROPIC LIQUID CRYSTALLINE NANOSYSTEMS WITH ENCAPSULATED BIOACTIVE MACROMOLECULES | UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2023-03-02 | — | — | WO | claimed |
| CN-115651230-A | PVC (polyvinyl chloride) coated polyester yarn and preparation method thereof | 浙江恒百华化纤有限公司 | 2023-01-31 | — | — | CN | claimed |
| WO-2022162132-A1 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | NOVO NORDISK A/S (DK) | 2022-08-04 | — | — | WO | claimed |
| CN-110636837-B | Pharmaceutical composition of CYP17 inhibitor and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-05-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338251-A1 | METHOD OF TREATING CANCER | PBK, GZMB, NPC1L1 | NAAA 1268/4885ALDH1A1 3990/4885HTT 4127/4885 |
| US-20260069697-A1 | METHOD OF TREATING CANCER | PBK, GZMB, KLRK1 | NAAA 1314/4885ALDH1A1 4469/4885HTT 4565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.